Advertisement
ABT vs DGX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Buy and DGX is a StrongBuy.
ABT in upward trend: 10-day moving average broke above 50-day moving average on November 02, 2026
The 10-day moving average for ABT crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on ABT as a result. In 42 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.
The Moving Average Convergence Divergence (MACD) for ABT just turned positive on October 09, 2026. Looking at past instances where ABT's MACD turned positive, the stock continued to rise in 32 of 54 cases over the following month. The odds of a continued upward trend are 59%.
ABT moved above its 50-day moving average on October 29, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +5.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where ABT advanced for three days, in 170 of 304 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 136 of 264 cases where ABT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
Bearish Trend Analysis
The 10-day RSI Indicator for ABT moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 16 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 52%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 28 of 53 cases where ABT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ABT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
ABT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. ABT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.722) is normal, around the industry mean (4.142). P/E Ratio (35.461) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.853) is also within normal values, averaging (11.253). Dividend Yield (0.023) settles around the average of (0.011) among similar stocks. P/S Ratio (3.836) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 92 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ABT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
DGX in upward trend: 10-day moving average crossed above 50-day moving average on October 26, 2026
The 10-day moving average for DGX crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 78%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on DGX as a result. In 46 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 55%.
The Moving Average Convergence Divergence (MACD) for DGX just turned positive on October 15, 2026. Looking at past instances where DGX's MACD turned positive, the stock continued to rise in 20 of 42 cases over the following month. The odds of a continued upward trend are 48%.
DGX moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where DGX advanced for three days, in 193 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.
Bearish Trend Analysis
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DGX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 44%.
DGX broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for DGX entered a downward trend on October 26, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.754) is normal, around the industry mean (67.298). P/E Ratio (26.796) is within average values for comparable stocks, (4.239). Projected Growth (PEG Ratio) (1.546) is also within normal values, averaging (3.473). DGX's Dividend Yield (0.013) is considerably higher than the industry average of (0.002). P/S Ratio (2.404) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 11 (best 1 - 100 worst), indicating outstanding price growth. DGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 18 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 58 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ABT | DGX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 28 | 33 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 92 | 8 | |
SMR RATING 1..100 | 68 | 58 | |
PRICE GROWTH RATING 1..100 | 43 | 11 | |
P/E GROWTH RATING 1..100 | 4 | 18 | |
SEASONALITY SCORE 1..100 | 24 | 12 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DGX's Valuation (8) in the Servicestothe Health Industry industry is significantly better than the same rating for ABT (78) in the Medical Specialties industry. This means that DGX’s stock grew significantly faster than ABT’s over the last 12 months.
DGX's Profit vs Risk Rating (8) in the Servicestothe Health Industry industry is significantly better than the same rating for ABT (92) in the Medical Specialties industry. This means that DGX’s stock grew significantly faster than ABT’s over the last 12 months.
DGX's SMR Rating (58) in the Servicestothe Health Industry industry is in the same range as ABT (68) in the Medical Specialties industry. This means that DGX’s stock grew similarly to ABT’s over the last 12 months.
DGX's Price Growth Rating (11) in the Servicestothe Health Industry industry is in the same range as ABT (43) in the Medical Specialties industry. This means that DGX’s stock grew similarly to ABT’s over the last 12 months.
ABT's P/E Growth Rating (4) in the Medical Specialties industry is in the same range as DGX (18) in the Servicestothe Health Industry industry. This means that ABT’s stock grew similarly to DGX’s over the last 12 months.
| ABT | DGX | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 52% | 2 days ago 70% |
| Stochastic ODDS (%) | 2 days ago 53% | 2 days ago 47% |
| Momentum ODDS (%) | 2 days ago 51% | 2 days ago 55% |
| MACD ODDS (%) | 2 days ago 59% | 2 days ago 48% |
| TrendWeek ODDS (%) | 2 days ago 54% | 2 days ago 61% |
| TrendMonth ODDS (%) | 2 days ago 51% | 2 days ago 56% |
| Advances ODDS (%) | 10 days ago 56% | 3 days ago 62% |
| Declines ODDS (%) | 6 days ago 56% | 9 days ago 44% |
| BollingerBands ODDS (%) | 2 days ago 50% | 2 days ago 47% |
| Aroon ODDS (%) | 2 days ago 52% | 2 days ago 37% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABT’s FA Score shows that 1 FA rating(s) are green while DGX’s FA Score has 4 green FA rating(s).
- ABT’s FA Score: 1 green, 4 red.
- DGX’s FA Score: 4 green, 1 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABT’s TA Score shows that 6 TA indicator(s) are bullish while DGX’s TA Score has 5 bullish TA indicator(s).
- ABT’s TA Score: 6 bullish, 4 bearish.
- DGX’s TA Score: 5 bullish, 5 bearish.
Price Growth
ABT (@Medical/Nursing Services) experienced а +0.97% price change this week, while DGX (@Medical Specialties) price change was +4.61% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.92%. For the same industry, the average monthly price growth was -5.08%, and the average quarterly price growth was +38.31%.
Reported Earning Dates
ABT is expected to report earnings on Jan 27, 2027.
DGX is expected to report earnings on Feb 04, 2027.
Industries' Descriptions
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Medical Specialties (-4.92% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
Advertisement
ABT and
Correlation & Price change
A.I.dvisor indicates that over the last year, ABT has been loosely correlated with MDT. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ABT jumps, then MDT could also see price increases.
DGX and
Correlation & Price change
A.I.dvisor indicates that over the last year, DGX has been closely correlated with LH. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if DGX jumps, then LH could also see price increases.